X0708 D LIVE 0001868532 Myrtelle Inc. 17 STATE STREET FL3, SUITE 350 NEW YORK NY NEW YORK 10004 (781) 621-2381 DELAWARE None Myrtelle LLC Corporation true 2021 Adrian Stecyk 17 State Street FL3, Suite 350 New York NY NEW YORK 10004 Executive Officer Director Chrystyna Bedrij 17 State Street FL3, Suite 350 New York NY NEW YORK 10004 Director Laurie Platek 17 State Street FL3, Suite 350 New York NY NEW YORK 10004 Director Debra Yu 17 State Street FL3, Suite 350 New York NY NEW YORK 10004 Director Michael Muhonen 17 State Street FL3, Suite 350 New York NY NEW YORK 10004 Director Thomas Barton 17 State Street FL3, Suite 350 New York NY NEW YORK 10004 Director Biotechnology Decline to Disclose 06b false 2025-12-11 false true true Exchanging Convertible Notes for Series B-2 Preferred Stock false 25000 55162634 30531749 24630885 Single private offering of Series B-2 Preferred Stock for cash and conversion of outstanding convertible notes (incl. interest). To date, $30,531,749 sold: ~$5,369,115 cash; ~$25,162,634 converted. false 21 0 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Myrtelle Inc. /s/ Adrian Stecyk Adrian Stecyk Chief Executive Officer and Director 2025-12-23